The Research and Science Policy Committee functions to ensure that the public affairs concerns of ASIP members are addressed and communicated appropriately to governing bodies. This is accomplished in cooperation with FASEB and the wider biomedical and research communities. Areas of interest to the ASIP Research and Science Policy Committee include policies that limit/regulate biomedical research, regulatory burden, human and animal subjects in research, translational research, gene patent law, health information technology as it applies to the research enterprise, creating a physician-scientist track for Pathology Board certification, NIH funding for graduate education, open access and open government initiatives, HIPPA policy impact on research, and issues related to biorepository and biosecurity regulation.
To contribute your point of view on any issue, please contact the ASIP Research and Science Policy Committee through Kelsey Dillehay McKillip, PhD Interim Chair, Research and Science Policy Committee.
Recent Posts
- ASIP Research and Science Policy Committee Action Alert!
- Advocate for Supplemental Funding for NIH-funded Investigators
- ASIP Member Dr. Dennis Jones Selected as Inaugural Early Career Representative to FASEB Board
Archived Newsletters
- May 2021
- March 2021
- October 2020
- November 2019
- September 2019
- July 2019
- June 2019
- April 2019
- February 2019
- December 2018
- November 2018
- September 2018
- August 2018
- July 2018
- June 2018
Advocating on behalf of funding for Pathology Research
(click here for quick and easy tools)
- Communicating Science FASEB resources
- Advocacy resources for scientists
- State and district information fact sheets
- NIH research funding overview
- FASEB Fact Sheet: The Value of Federally Funded Biomedical and Biological Research
Human Subjects Research Protection and Biomedical Ethics
- ASIP joins over 170 organizations objecting to changes to patent law that would allow patenting of naturally occurring genes (June 2019)
- National Academies report Returning Individual Research Results to Participants: Guidance for a New Research Paradigm (July 2018)
- Dreyfus and Sobel add ASIP’s voice to return of results discussion: Response to Evans Commentary; Evans original Commentary; Evans rebuttal (July 2018)
- Recommendations from MRTC Center Return of Individual Results to Participants (October 2018)
- Sobel and Dreyfus stress transformative nature of proposed changes to Common Rule and rules governing return of results (December 2016)
Research Funding, Submission and Related Concerns
- Societies call on Congress to complete 2020 appropriations (December 2019)
- ASIP joins coalition opposing EPA’s efforts restricting the use of the best available science in policymaking (November 2019)
- ASIP joins community letter stressing the importance of timely 2020 federal appropriations (October 2019)
- ASIP supports ongoing commitment to NSF’s fellowship program (October 2019)
- ASIP joins coalition requesting changes to recently announced human fetal tissue research restrictions (September 2019)
- ASIP stands with over 90 organizations opposed to new fetal tissue restrictions (July 2019)
- ASIP signs on to Plan S letter (February 2019)
- ASIP joins others in opposition to fetal tissue research prohibitions (September 2018)
- ASIP joins 69 organizations in opposing proposed EPA transparency rule (July 2018)
- ASIP joins Ad Hoc Group for Medical Research in seeking appropriate FY 2019 funding (May 2018)
- Instrumentation: federal grants & programs for the life sciences, FASEB resource (April 2018)
- Perceptions of Science in America report from AAAS (March 2018)
- ASIP as FASEB member society objects to President’s 2019 budget proposal (February 2018)
- ASIP joins others in opposition to cuts to facilities & administration expenses (August 2017)
- Report on strengthening canadian research funding (April 2017)
- National Academies Report – Fostering Integrity in Research (2017)
- FASEB Sustaining Discovery discussion framework (January 2015)
Laboratory Developed Tests
- FDA discussion paper on LDTs (January 2017)
Basic Experimental Studies Involving Humans & the Definition of Clinical Trial
- NIH comments and extends registration requirement for basic experimental trials (July 2019)
- Clarification from NIH on biospecimen research not considered a clinical trial (August 2018)
Clinician Scientist Workforce
- NIGMS summary of MSTP comments (February 2018)
- NIH Update from Physician Scientist Work Group (June 2017)
- ASIP joins key organizations highlighting importance of implimenting physician scientist support recommendations (September 2016)
- American Board of Medical Specialties 2016 report on physician-scientists (June 2016)
- NIH report: Physician Scientist Workforce Working Group Report (June 2014)
Animals in Research
- ILAR webinar on animal regulations (January 2018)
- FASEB-AAMC-COGR report on reforming animal regulations to reduce regulatory burden (October 2017)
- FASEB database on research organism providers (November 2016)
- White paper: critical role of nonhuman primates in medical research (September 2016)
- FASEB fact sheets (November 2015)
- FASEB statement supporting air transport of animals (September 2014)
- FASEB report: The Threat of Extremism to Medical Research: Best Practices to Mitigate Risk through Preparation and Communication
Administrative Burden
- FASEB releases shared resources report (October 2017)
- National Science Board Report: Reducing Investigators Administrative Workload for Federally Funded Research
(March 2014)
Resources for Next-Generation Scientists
- Request extension of early stage investigator status – now available online (August 2019)
- National Academies report on next generation scientists (May 2018)
- Next-Generation Research Initiative website (June 2017)
- NIH presentation on Next Generation Research Initiative (June 2017)
Click here for more Science Policy Information Science Policy News